These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 8029812

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [3-[4-(4,5-Diphenyl-2-oxazolyl)-5-oxazolyl]phenoxy]acetic acid (BMY 45778) is a potent non-prostanoid prostacyclin partial agonist: effects on platelet aggregation, adenylyl cyclase, cAMP levels, protein kinase, and iloprost binding.
    Seiler SM, Brassard CL, Federici ME, Romine J, Meanwell NA.
    Prostaglandins; 1997 Jan; 53(1):21-35. PubMed ID: 9068064
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.
    Merritt JE, Hallam TJ, Brown AM, Boyfield I, Cooper DG, Hickey DM, Jaxa-Chamiec AA, Kaumann AJ, Keen M, Kelly E.
    Br J Pharmacol; 1991 Jan; 102(1):251-9. PubMed ID: 1710526
    [Abstract] [Full Text] [Related]

  • 5. A study of prostacyclin mimetics distinguishes neuronal from neutrophil IP receptors.
    Wise H, Qian YM, Jones RL.
    Eur J Pharmacol; 1995 May 24; 278(3):265-9. PubMed ID: 7589166
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Nonprostanoid prostacyclin mimetics. 5. Structure-activity relationships associated with [3-[4-(4,5-diphenyl-2-oxazolyl)-5- oxazolyl]phenoxy]acetic acid.
    Meanwell NA, Romine JL, Rosenfeld MJ, Martin SW, Trehan AK, Wright JJ, Malley MF, Gougoutas JZ, Brassard CL, Buchanan JO.
    J Med Chem; 1993 Nov 26; 36(24):3884-903. PubMed ID: 7504734
    [Abstract] [Full Text] [Related]

  • 10. Nonprostanoid prostacyclin mimetics. 4. Derivatives of 2-[3-[2-(4,5-diphenyl-2-oxazolyl)ethyl]phenoxy]acetic acid substituted alpha to the oxazole ring.
    Meanwell NA, Rosenfeld MJ, Wright JJ, Brassard CL, Buchanan JO, Federici ME, Fleming JS, Gamberdella M, Hartl KS, Zavoico GB.
    J Med Chem; 1993 Nov 26; 36(24):3871-83. PubMed ID: 8254619
    [Abstract] [Full Text] [Related]

  • 11. Prostacyclin receptor-independent inhibition of phospholipase C activity by non-prostanoid prostacyclin mimetics.
    Chow KB, Wong YH, Wise H.
    Br J Pharmacol; 2001 Dec 26; 134(7):1375-84. PubMed ID: 11724742
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The inhibitory effects of non-prostanoid prostacyclin mimetics on rat neutrophil function.
    Wise H.
    Prostaglandins Leukot Essent Fatty Acids; 1996 May 26; 54(5):351-60. PubMed ID: 8832764
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Developmental Differences in Platelet Inhibition Response to Prostaglandin E1.
    Palma-Barqueros V, Torregrosa JM, Caparrós-Pérez E, Mota-Pérez N, Bohdan N, Llanos MDC, Begonja AJ, Sola-Visner M, Vicente V, Teruel-Montoya R, Rivera J, Ferrer-Marín F.
    Neonatology; 2020 May 26; 117(1):15-23. PubMed ID: 31786577
    [Abstract] [Full Text] [Related]

  • 18. Imidazoquinoline derivatives: potent inhibitors of platelet cAMP phosphodiesterase which elevate cAMP levels and activate protein kinase in platelets.
    Seiler S, Gillespie E, Arnold AJ, Brassard CL, Meanwell NA, Fleming JS.
    Thromb Res; 1991 Apr 26; 62(1-2):31-42. PubMed ID: 1649498
    [Abstract] [Full Text] [Related]

  • 19. Primate vascular responses to octimibate, a non-prostanoid agonist at the prostacyclin receptor.
    Merritt JE, Brown AM, Bund S, Cooper DG, Egan JW, Hallam TJ, Heagerty AM, Hickey DM, Kaumann AJ, Keen M.
    Br J Pharmacol; 1991 Jan 26; 102(1):260-6. PubMed ID: 2043927
    [Abstract] [Full Text] [Related]

  • 20. Prostacyclin receptor desensitization is a reversible phenomenon in human platelets.
    Fisch A, Tobusch K, Veit K, Meyer J, Darius H.
    Circulation; 1997 Aug 05; 96(3):756-60. PubMed ID: 9264479
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.